Jefferies Group LLC X Biotech Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$8.64 - $11.71 $99,982 - $135,508
-11,572 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$10.95 - $16.07 $126,713 - $185,962
11,572 New
11,572 $58,000
Q2 2019

Aug 14, 2019
SELL
$6.99 - $11.27 $101,355 - $163,415
-14,500 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$5.05 - $11.62 $73,225 - $168,490
14,500 New
14,500 $160,000

Others Institutions Holding XBIT

# of Institutions
49
Shares Held
4.87M
Call Options Held
0
Put Options Held
0
View Full List

About XBiotech Inc.

XBIT Quotes by TradingView
  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $203M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email